Fig. 2: Probability that RBD is reached for weekly dose levels (pooled data from both studies). | British Journal of Cancer

Fig. 2: Probability that RBD is reached for weekly dose levels (pooled data from both studies).

From: Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Fig. 2

Mean probability that RBD is reached for xentuzumab 1000 mg/week is shown in bold. Horizontal lines represent the median, diamonds represent the mean, and boxes represent the 25th and 75th percentiles. Whiskers represent the 2.5th and 97.5th percentiles. EVT extreme value theory, RBD relevant biological dose.

Back to article page